Policy Analysis No. 72

Compassion vs Control: FDA Investigational-Drug Regulation

By Dale H. Gieringer
May 20, 1986

Executive Summary

“The basic problem is, I don’t have as much control over what I can do to get well as I want.”

—AIDS patient[1]

“I think the FDA should recognize its responsibility for the denial of lifesaving technology.”

—Robert Jarvik, developer of the artificial heart[2]

Read the Full Policy Analysis

Dale H. Gieringer is a writer and policy analyst affiliated with the Decisions and Ethics Center of Stanford University.